- Home
- Research
- Mental Health
- Clinical and Sociodemographic Characteristics of Young People With Early Psychosis: Comparing Cannabis Users and Non-Users in a Specialized Early Intervention Setting.
Why cannabis-related psychosis can be difficult to diagnose early
Clinical and Sociodemographic Characteristics of Young People With Early Psychosis: Comparing Cannabis Users and Non-Users in a Specialized Early Intervention Setting.
AI Summary
This retrospective study examined 509 young people aged 18–35 receiving early psychosis treatment, comparing those diagnosed with cannabis-induced psychotic disorder (CIPD), those with a non-substance-induced psychotic disorder and concurrent cannabis use (NSIPD+C), and those with a non-substance-induced psychotic disorder without reported concurrent cannabis use (NSIPD). The groups represented 33.3%, 7%, and 42.6% of participants, respectively. The study found no meaningful group differences in sociodemographic characteristics, duration of untreated psychosis, or measures of functioning.
People with NSIPD remained in treatment longer, showed greater treatment motivation, and were more likely to leave treatment in line with clinicians’ recommendations than participants in the CIPD and NSIPD+C groups. The authors conclude that these background and clinical measures do not reliably distinguish the type of psychosis when cannabis use and psychotic symptoms occur together. For cannabis users and families, the findings highlight why early professional assessment is important: cannabis involvement alone may not clarify diagnosis, and low-threshold early-intervention services may help people access care before delays become substantial.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Mental Health research papers you might find interesting.
Review finds mixed evidence on cannabis and tobacco co-use effects
EEG profiles recurred across groups, but individual reliability was low
Review finds promise in acidic cannabinoids, but human benefits remain unproven
Explore More Research
Stay informed about the latest cannabis science.